Visualization of Myc/Max/Mad family dimers and the competition for dimerization in living cells

被引:109
作者
Grinberg, AV
Hu, CD
Kerppola, TK [1 ]
机构
[1] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA
关键词
D O I
10.1128/MCB.24.10.4294-4308.2004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Myc and Mad family proteins play opposing roles in the control of cell growth and proliferation. We have visualized the subeellular locations of complexes formed by Myc/Max/Mad family proteins using bimolecular fluorescence complementation (BiFC) analysis. Max was recruited to different sulmuclear locations by interactions with Myc versus Mad family members. Complexes formed by Max with Mxi1, Mad3, or Mad4 were enriched in nuclear foci, whereas complexes formed with Myc were more uniformly distributed in the nucleoplasm. Mad4 was localized to the cytoplasm when it was expressed separately, and Mad4 was recruited to the nucleus through dimerization with Max. The cytoplasmic localization of Mad4 was determined by a CRM1-dependent nuclear export signal located near the amino terminus. We compared the relative efficiencies of complex formation among Myc, Max, and Mad family proteins in living cells using multicolor BiFC analysis. Max formed heterodimers with the basic helix-loop-helix leucine zipper (bHLHZIP) domain of Myc (bMyc) more efficiently than it formed homodimers. Replacement of two amino acid residues in the leucine zipper of Max reversed the relative efficiencies of homo- and heterodimerization in cells. Surprisingly, Mad3 formed complexes with Max less efficiently than bMyc, whereas Mad4 formed complexes with Max more efficiently than bMyc. The distinct subcellular locations and the differences between the efficiencies of dimerization with Max indicate that Mad3 and Mad4 are likely to modulate transcription activation by Myc at least in part through distinct mechanisms.
引用
收藏
页码:4294 / 4308
页数:15
相关论文
共 47 条
[31]   The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc [J].
McMahon, SB ;
Wood, MA ;
Cole, MD .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (02) :556-562
[32]   THE LEUCINE ZIPPERS OF THE HLH-LZ PROTEINS MAX AND C-MYC PREFERENTIALLY FORM HETERODIMERS [J].
MUHLEGOLL, C ;
NILGES, M ;
PASTORE, A .
BIOCHEMISTRY, 1995, 34 (41) :13554-13564
[33]   X-ray structures of Myc-Max and Mad-Max recognizing DNA: Molecular bases of regulation by proto-oncogenic transcription factors [J].
Nair, SK ;
Burley, SK .
CELL, 2003, 112 (02) :193-205
[34]   Gene-target recognition among members of the Myc superfamily and implications for oncogenesis [J].
O'Hagan, RC ;
Schreiber-Agus, N ;
Chen, K ;
David, G ;
Engelman, JA ;
Schwab, R ;
Alland, L ;
Thomson, C ;
Ronning, DR ;
Sacchettini, JC ;
Meltzer, P ;
DePinho, RA .
NATURE GENETICS, 2000, 24 (02) :113-119
[35]   Sequential expression of the MAD family of transcriptional repressors during differentiation and development [J].
Quéva, C ;
Hurlin, PJ ;
Foley, KP ;
Eisenman, RN .
ONCOGENE, 1998, 16 (08) :967-977
[36]  
REDDY CD, 1992, ONCOGENE, V7, P2085
[37]   AN AMINO-TERMINAL DOMAIN OF MXI1 MEDIATES ANTI-MYC ONCOGENIC ACTIVITY AND INTERACTS WITH A HOMOLOG OF THE YEAST TRANSCRIPTIONAL REPRESSOR SIN3 [J].
SCHREIBERAGUS, N ;
CHIN, L ;
CHEN, K ;
TORRES, R ;
RAO, G ;
GUIDA, P ;
SKOULTCHI, AI ;
DEPINHO, RA .
CELL, 1995, 80 (05) :777-786
[38]   Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity [J].
Sommer, A ;
Hilfenhaus, S ;
Menkel, A ;
Kremmer, E ;
Seiser, C ;
Loidl, P ;
Luscher, B .
CURRENT BIOLOGY, 1997, 7 (06) :357-365
[39]   Identification and characterization of specific DNA-binding complexes containing members of the Myc/Max/Mad network of transcriptional regulators [J].
Sommer, A ;
Bousset, K ;
Kremmer, E ;
Austen, M ;
Lüscher, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (12) :6632-6642
[40]   Design and properties of a myc derivative that efficiently homodimerizes [J].
Soucek, L ;
Helmer-Citterich, M ;
Sacco, A ;
Jucker, R ;
Cesareni, G ;
Nasi, S .
ONCOGENE, 1998, 17 (19) :2463-2472